Conditions
Hormone Therapy Blood Clot Risk Study
A new study examines the thromboembolic risks of menopausal hormone therapy. Separately, research reveals significant gender disparities in the diagnosis of autoimmune conditions.
#Conditions
Every Womens Health story tagged Conditions.
Conditions
Vitamin B5 biomarkers in human milk reveal mammary gland function
A new study analyzing over 1,500 milk samples identifies molecular patterns linking maternal vitamin B5 levels to milk production and infant growth.
Conditions
Flu and COVID Vaccine Recommendations for Fall 2026
Updated mRNA flu and COVID-19 vaccines are available this fall, with medical societies strongly recommending October vaccination for high-risk groups.
Conditions
FDA Grants Priority Review For Elinzanetant Hot Flash Treatment
The FDA has granted priority review to elinzanetant for treating hot flashes in women undergoing endocrine therapy for HR+ breast cancer.
Conditions
Sex-based discrimination in medicine costs women's lives
Letters to the Guardian highlight systemic sex-based discrimination in healthcare, where women receive less active treatment than men for the same conditions.
Conditions
Opportunistic Salpingectomy Offers Ovarian Cancer Prevention
Removing fallopian tubes during other abdominal surgeries can drastically cut ovarian cancer risk.
Conditions
Study finds women less likely to receive surgery and stents
A global review of 38 studies reveals women with conditions like heart disease, kidney failure, and Parkinson's are less often offered surgery and stents.
Conditions
Azithromycin Use Rises, Cuts Post-C-Section Infections
Real-world U.S. data shows increased use of azithromycin during unscheduled cesarean deliveries is linked to a significant drop in postpartum infections.
Conditions
FDA Approves Camizestrant for Early ESR1-Mutant Breast Cancer
The FDA granted accelerated approval to camizestrant for HR+/HER2- breast cancer when ESR1 resistance mutations are first detected during initial therapy.
Conditions
Medicare's $50 GLP-1 Discount Excludes Patients With Certain Conditions
A new Medicare pilot program offers GLP-1 weight-loss drugs for $50 a month, but patients with FDA-approved conditions like sleep apnea are excluded.
Conditions
Urine test detects 92% of bladder cancers
A new at-home urine test trialled by the NHS can identify 92% of bladder cancer cases, potentially reducing the need for invasive cystoscopies.
Conditions
CheckCausesObesity.com Launches Screening Tool
A new online tool offers a science-based method to screen for obesity's diverse causes, ranging from lifestyle factors to medical conditions.
Conditions
GLP-1 drugs cut infection risk in diabetes
Two new studies suggest GLP-1 receptor agonist drugs, used for type 2 diabetes and obesity, may significantly reduce the risk of serious infections.